Your browser doesn't support javascript.
loading
Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells.
Leclerc, Justine; Garandeau, David; Pandiani, Charlotte; Gaudel, Céline; Bille, Karine; Nottet, Nicolas; Garcia, Virginie; Colosetti, Pascal; Pagnotta, Sophie; Bahadoran, Philippe; Tondeur, Garance; Mograbi, Baharia; Dalle, Stéphane; Caramel, Julie; Levade, Thierry; Ballotti, Robert; Andrieu-Abadie, Nathalie; Bertolotto, Corine.
Afiliação
  • Leclerc J; Team 1, Biology and Pathologies of Melanocytes, Equipe labellisée ARC 2015, Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Garandeau D; Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Pandiani C; Team 1, Biology and Pathologies of Melanocytes, Equipe labellisée ARC 2015, Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Gaudel C; Team 1, Biology and Pathologies of Melanocytes, Equipe labellisée ARC 2015, Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Bille K; Team 1, Biology and Pathologies of Melanocytes, Equipe labellisée ARC 2015, Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Nottet N; Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Garcia V; Team 4, Sphingolipids, Metabolism, Cell Death and Tumor Progression, Université Toulouse III, Toulouse, Inserm, UMR1037, CRCT, Toulouse, France.
  • Colosetti P; CarMeN Laboratory, INSERM U1060, INRA1397, INSA, Lyon, France.
  • Pagnotta S; Université Côte d'Azur, Centre Commun de Microscopie Appliquée, Nice, France.
  • Bahadoran P; Team 1, Biology and Pathologies of Melanocytes, Equipe labellisée ARC 2015, Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Tondeur G; CHU NICE, Département de Dermatologie, Nice, France.
  • Mograbi B; Université de Lyon, Inserm, U1052, CNRS 5286, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
  • Dalle S; INSERM ERI21/EA 4319, Nice, F-06107, France.
  • Caramel J; Université de Lyon, Inserm, U1052, CNRS 5286, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
  • Levade T; Université de Lyon, Inserm, U1052, CNRS 5286, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
  • Ballotti R; Team 4, Sphingolipids, Metabolism, Cell Death and Tumor Progression, Université Toulouse III, Toulouse, Inserm, UMR1037, CRCT, Toulouse, France.
  • Andrieu-Abadie N; Team 1, Biology and Pathologies of Melanocytes, Equipe labellisée ARC 2015, Université Côte d'Azur, Inserm U1065, C3M, Nice, France.
  • Bertolotto C; Team 4, Sphingolipids, Metabolism, Cell Death and Tumor Progression, Université Toulouse III, Toulouse, Inserm, UMR1037, CRCT, Toulouse, France.
Oncogene ; 38(8): 1282-1295, 2019 02.
Article em En | MEDLINE | ID: mdl-30254208
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Proliferação de Células / Fator de Transcrição Associado à Microftalmia / Ceramidase Ácida / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Oncogene Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Proliferação de Células / Fator de Transcrição Associado à Microftalmia / Ceramidase Ácida / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Oncogene Ano de publicação: 2019 Tipo de documento: Article